Patent Assignment
Reel/Frame 060366/0545
Change of Name
Recorded: 2022-06-30
Pages: 5
Assignor
ARGENX BVBA
Executed: 2020-06-03
Assignee
ARGENX BV
INDUSTRIEPARK ZWIJNAARDE 7, GHENT, 9052, BELGIUM
Covered Property
(1)
Fcrn Antagonists and Methods of Use
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 11, 2016
From: ULRICHTS, PETER; BLANCHETOT, CHRISTOPHE; DREIER, TORSTEN; DE HAARD, JOHANNES
To: ARGEN-X B.V.
Reel/Frame 037713/0261 →
Assignment of Assignor's Interest
Feb 11, 2016
From: WARD OBER, E. SALLY
To: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 037713/0604 →
Change of Name
May 3, 2017
From: ARGEN-X B.V.
To: ARGEN-X N.V.
Reel/Frame 042261/0226 →
Assignment of Assignor's Interest
Feb 26, 2018
From: ARGENX SE
To: ARGENX BVBA
Reel/Frame 045441/0032 →
Change of Name
Feb 26, 2018
From: ARGEN-X N.V.
To: ARGENX SE
Reel/Frame 045441/0013 →
Change of Name
Sep 14, 2022
From: ARGENX BVBA
To: ARGENX BV
Reel/Frame 061090/0578 →
Confirmatory License
Nov 14, 2022
From: UT SOUTHWESTERN MEDICAL CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 061933/0702 →